Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave
26th Aug 2025 09:14
(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons. Read More
| Price | 243.00p on 06-10-2025 at 08:35:13 |
|---|---|
| Change | 1.00p 0.41% |
| Buy | 248.00p |
| Sell | 242.00p |
| Last Trade: | Buy 4.00 at 246.40p |
| Day's Volume: | 4,006 |
| Last Close: | 242.00p |
| Open: | 244.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 243.00p - 244.00p |
| 52wk Range: | 187.50p - 336.00p |
| Market Capitalisation: | £2.09b |
| VWAP: | 243.50414p |
| Shares in Issue: | 859.34m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 4 | 246.40p | Ordinary |
09:08:24 - 06-Oct-25 |
| Buy* | 2 | 246.00p | SI Trade |
08:32:18 - 06-Oct-25 |
| Sell* | 2,000 | 243.00p | Automatic Execution |
08:32:18 - 06-Oct-25 |
| Sell* | 740 | 242.00p | Uncrossing Trade |
16:35:24 - 03-Oct-25 |
| Sell* | 11 | 242.00p | Automatic Execution |
16:29:58 - 03-Oct-25 |
| Sell* | 370 | 242.00p | Automatic Execution |
15:45:37 - 03-Oct-25 |
| Buy* | 469 | 243.00p | Automatic Execution |
15:31:09 - 03-Oct-25 |
| Buy* | 565 | 243.00p | Automatic Execution |
15:31:09 - 03-Oct-25 |
| Sell* | 98 | 242.00p | Automatic Execution |
14:50:55 - 03-Oct-25 |
| Sell* | 436 | 242.00p | Automatic Execution |
13:06:00 - 03-Oct-25 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Oct 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at ESMO |
| 30th Sep 2025 9:30 am | RNS | Total Voting Rights |
| 12th Sep 2025 7:00 am | RNS-R | HUTCHMED to Present R&D Updates on October 31 2025 |
| 5th Sep 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at CSCO |
| 26th Aug 2025 7:00 am | RNS | Directorate Change |
| 20th Aug 2025 7:00 am | RNS-R | HUTCHMED Completes Enrollment of Phase III Trial |
| 7th Aug 2025 12:00 pm | RNS | 2025 Interim Results |
| 3rd Jul 2025 9:30 am | RNS | HUTCHMED to Announce 2025 Half-Year Results |
| 2nd Jul 2025 10:00 am | RNS | Update on Joint Corporate Brokers in London |
| 30th Jun 2025 9:30 am | RNS | China Approval based on Phase III SACHI Trial |